Inactive Instrument

News GW PHARMACEUTICALS OTC Markets

Stocks

GWPRF

GB0030544687

Biotechnology & Medical Research

All News

21-08-10	Gw Pharmaceuticals Receives Approval for Epidyolex (Cannabidiol) from the MHRA for the Treatment of Seizures Associated with Tuberous Sclerosis Complex	CI
21-05-10	GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from S&P Global BMI Index	CI
21-05-05	GW PHARMACEUTICALS PLC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
21-05-05	GW Pharmaceuticals : Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc	PR
21-05-04	GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from NASDAQ Composite Index	CI
21-05-03	GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from NASDAQ Biotechnology Index	CI
21-05-03	GW PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
21-05-03	Gw Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2021	CI
21-04-29	GW Pharmaceuticals : recognised for leadership in prescription cannabis-based medicines with prestigious Queen's Award for Enterprise in Innovation	AQ
21-04-29	GW Pharmaceuticals : Highest British business award goes to cannabis drug developer, GW Pharmaceuticals	AQ
21-04-28	GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for Enterprise in Innovation	GL
21-04-26	GW PHARMACEUTICALS PLC : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
21-04-26	GW Pharmaceuticals : Shareholders' Green-light $7.2 Billion Sale To Jazz Pharmaceuticals	MT
21-04-23	GW Pharmaceuticals : Shareholders OK Takeover by Jazz Pharmaceuticals	MT
21-04-23	GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals	GL
21-04-21	GW Pharmaceuticals : receives European Commission approval for EPIDYOLEX (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex	AQ
21-04-20	GW PHARMACEUTICALS PLC : Other Events (form 8-K)	AQ
21-04-20	GW Pharmaceuticals plc Receives European Commission Approval for EPIDYOLEX® (Cannabidiol) for the Treatment of Seizures Associated with Tuberous Sclerosis Complex	CI
21-04-20	GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex	GL
21-04-14	GW PHARMACEUTICALS PLC : Other Events (form 8-K)	AQ
21-04-13	GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting	GL
21-04-08	Insider Trends: 90-Days of Insider Buying at GW Pharmaceuticals Eased Back with Share Disposition	MT
21-03-23	GW PHARMACEUTICALS PLC : Other Events (form 8-K)	AQ
21-03-01	GW Pharmaceuticals : receives positive CHMP opinion for EPIDYOLEX for use as treatment of seizures associated with Tuberous Sclerosis Complex	AQ
21-02-26	GW PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ